Franchi, Francesco <br/><br/>
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y  [electronic resource] 

 -  Journal of the American Heart Association  04 2020 
 - e015865 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.120.015865  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aspirin--adverse effects<br/>Dual Anti-Platelet Therapy--adverse effects<br/>Female<br/>Florida<br/>Hemorrhage--chemically induced<br/>Humans<br/>Lactones--adverse effects<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--blood<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Prasugrel Hydrochloride--adverse effects<br/>Prospective Studies<br/>Purinergic P2Y Receptor Antagonists--adverse effects<br/>Pyridines--adverse effects<br/>Thrombosis--blood<br/>Ticagrelor--adverse effects<br/>Time Factors<br/>Treatment Outcome